Depression and Anxiety During the COVID-19 Pandemic: Epidemiology, Mechanism, and Treatment
Neuroscience Bulletin · 2023-04 · 39 (4) · 675-684
DOI: 10.1007/s12264-022-00970-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuroscience Bulletin, online erschienen am 21.11.2022. Verfasst von Chunyan Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, 230032, China. Hauptthemen laut MEDLINE: Anxiety, COVID-19, Depression, Pandemics. Die Arbeit wurde bisher 134-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
The Coronavirus Disease 2019 (COVID-19) pandemic has had an adverse impact on the physical and mental health of the public worldwide. In addition to illness in patients with COVID-19, isolated people and the general population have experienced mental health problems due to social distancing policies, mandatory lockdown, and other psychosocial factors, and the prevalence of depression and anxiety significantly increased during the pandemic. The purpose of this review is to elucidate the epidemiology, contributing factors, and pathogenesis of depression and anxiety. during the pandemic. These findings indicate that physicians and psychiatrists should pay more attention to and identify those with a high risk for mental problems, such as females, younger people, unmarried people, and those with a low educational level. In addition, researchers should focus on identifying the neural and neuroimmune mechanisms involved in depression and anxiety, and assess the intestinal microbiome to identify effective biomarkers. We also provide an overview of various intervention methods, including pharmacological treatment, psychological therapy, and physiotherapy, to provide a reference for different populations to guide the development of optimized intervention methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, 230032, China.
- Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei, 230032, China.
- Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei, 230032, China.
- Department of Psychiatry, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
- Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
- School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, 230032, China. wangkai1964@126.com.
Zitieren
APA
Zhu, C., Zhang, T., Li, Q., Chen, X., & Wang, K. (2023). Depression and Anxiety During the COVID-19 Pandemic: Epidemiology, Mechanism, and Treatment. Neuroscience Bulletin, 39(4), 675-684. https://doi.org/10.1007/s12264-022-00970-2
Vancouver
Zhu C, Zhang T, Li Q, Chen X, Wang K. Depression and Anxiety During the COVID-19 Pandemic: Epidemiology, Mechanism, and Treatment. Neuroscience Bulletin. 2023;39(4):675-684. doi:10.1007/s12264-022-00970-2
BibTeX
@article{Zhu2023,
author = {Zhu, Chunyan and Zhang, Ting and Li, Qianqian and Chen, Xingui and Wang, Kai},
title = {Depression and Anxiety During the COVID-19 Pandemic: Epidemiology, Mechanism, and Treatment},
journal = {Neuroscience Bulletin},
year = {2023},
volume = {39},
number = {4},
pages = {675--684},
doi = {10.1007/s12264-022-00970-2}
}
EUVIMED